References
- World Health Organization. HIV/AIDS. 2020 [cited 2020 Sept 16]. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids
- Ministry of Health of the Russian Federation. Rubricator clinical guidelines. HIV infection in adults. 2017 [cited 2019 Oct 9]. Available from: http://cr.rosminzdrav.ru/#!/schema/899
- World Health Organization. HIV/AIDS surveillance in Europe 2019. 2019 [cited 2020 Sept 22]. Available from: https://www.euro.who.int/en/health-topics/communicable-diseases/hivaids/publications/2019/hivaids-surveillance-in-europe-2019
- Federal Service for Supervision of Consumer Rights Protection and Human Well-Being. On the state of the sanitary and epidemiological well-being of the population of the Russian Federation in 2020. 2019 [cited 2021 Jul 11]. Available from: https://rospotrebnadzor.ru/about/info/news/page1.php?ELEMENT_ID=18266 • shows the epidemiology of HIV in the Russian Federation.
- Federal Budget Institution of Science. HIV infection in the Russian Federation on December 31, 2020. 2018 [cited 2021 Mar 9]. Available from: http://www.hivrussia.info/wp-content/uploads/2021/03/VICH-infektsiya-v-Rossijskoj-Federatsii-na-31.12.2020-.pdf
- National Scientific Society of Infectious Diseases. Recommendations for the treatment and chemoprevention of HIV and associated diseases. 2019 [cited 2020 Oct 7]. Available from: http://www.hivrussia.info/wp-content/uploads/2019/12/Rekomendatsii-po-lecheniyu-VICH-infektsii-i-svyazannyh-s-nej-zabolevanijhimioprofilaktike-zarazheniya-VICH.pdf
- Ministry of Health of the Russian Federation. Approving the state strategy to combat the spread of HIV in Russia through 2020 and beyond 2016. [cited 2020 Oct 7]. Available from: http://government.ru/en/docs/24983/
- Ministry of Health of the Russian Federation. Approval of the standard first-line ART for special cases of HIV infection 2018. Order No. 799n. 2018 Nov 20 [cited 2020 Oct 7]. Available from: https://itpcru.org/2019/02/20/novye-standarty-pervichnoj-mediko-sanitarnoj-pomoshhi-vzroslym-pri-bolezni-vyzvannoj-vich/
- Holownia-Voloskova M, Vorobiev PA, Grinin M, et al. Drug policy in the Russian Federation. Value Health Reg Issues. 2018 Sep;16:106–111.
- Government of the Russian Federation. About approval of Rules of forming of lists of medicines for medical application and the minimum range of the medicines necessary for delivery of health care, 2020. Order No. 871. 2014 Aug 28 [cited 2020 Sept 25]. Available from: https://cis-legislation.com/document.fwx?rgn=69386 •• discusses the Russian regulatory framework.
- Center for Healthcare Quality Assessment and Control. Ministry of Health of the Russian Federation. 2020 [cited 2020 Sept 25]. Available from: https://rosmedex.ru/en/about-us/ •• discusses the Russian regulatory framework.
- Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Value Health. 2013 Mar-Apr;16(2):e1–5.
- Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget impact analysis-principles of good practice: report of the ISPOR 2012 budget impact analysis good practice II task force. Value Health. 2014 Jan-Feb;17(1):5–14.
- Register of Medicines of the Russian Federation. cited 2019 Oct 12. Available from: https://grls.rosminzdrav.ru
- Orkin C, Squires KE, Molina JM, et al. Doravirine/lamivudine/tenofovir disoproxil fumarate is non-inferior to efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive adults with human immunodeficiency virus-1 infection: week 48 results of the DRIVE-AHEAD Trial. Clin Infect Dis. 2019 Feb 1;68(4):535–544.
- Cohen C, Wohl D, Arribas JR, et al. Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults. AIDS. 2014 Apr 24;28(7):989–997.
- Bucher HC, Guyatt GH, Griffith LE, et al. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997 Jun;50(6):683–691.
- Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services. [cited 2020 Sep 30]. Available from: https://aidsinfo.nih.gov/guidelines